Prevention of abnormal scarring in woundhealing

S100 proteins (i.e. Psoriasin, Koebnerisin) for the prevention

of abnormal scarring by reduction of excessive collagen and extracellular matrix production early after wounding.

Further Information: PDF

Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0

Contact
Peer Biskup

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Duke-NUS and NHCS scientists first in the world to regenerate diseased kidney

Blocking an immune-regulating protein reverses the damage caused by acute and chronic kidney disease, a preclinical study suggests. In a world first, scientists at Duke-NUS Medical School, the National Heart…

Unconventional superconductivity found in kagome metal

Physicists using advanced muon spin spectroscopy at Paul Scherrer Institute PSI make the missing link between their recent breakthrough in a kagome metal and unconventional superconductivity. The team uncovered an…

Discovery of new ice may change understanding of water

Researchers at UCL (University College London) have discovered a new type of ice that more closely resembles liquid water than any other known ices and that may rewrite our understanding…

Partners & Sponsors